Clinical Trial Update: Fecal Microbiota Transplantation for C. Difficile Infection in Solid Organ Transplant Recipients [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating fecal microbiota transplantation for recurrent Clostridioides difficile infection in solid organ transplant recipients was ter…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Clostridioides Difficile Infection

Drugs mentioned

• Fecal microbiota transplantation (fecal microbiota transplantation)

Snippet

Sponsor: University of Wisconsin, Madison | Conditions: Clostridium Difficile Infection Recurrence | Phase 2 | Status: TERMINATED | Results posted: 2025-01-09